Literature DB >> 10391375

Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas.

A Bànkfalvi1, K Schmitz, T Mock, M Kemper, C Cubick, W Böcker.   

Abstract

The present study investigated (i) the relationship between standardised morphometric AgNOR parameters (argyrophilic nucleolar organiser region-associated proteins) and MIB1 growth fraction, and (ii) their correlation with immunohistochemical p53, sex steroid receptor status and histopathological differentiation grade in serial paraffin sections from 39 breast carcinomas. Ten sections were double-stained for AgNOR/MIB1. AgNOR parameters correlated significantly with MIB1 growth fraction and p53 protein expression. Significant inverse correlation was found between proliferation markers and oestrogen/progesterone receptor status and histopathological grade. AgNOR expression was significantly higher in cycling (MIB1 positive) tumour cells, than in resting (MIB1 negative) ones, however with exceptions. We conclude, that standardised AgNOR parameters correlate with markers of increased malignant potential in breast carcinomas. However, AgNORs seem to reflect proliferation independent cellular and nucleolar activity of tumour cells, as well. We recommend the use of standardised AgNOR analysis for obtaining sound results in routine paraffin sections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10391375      PMCID: PMC4615186          DOI: 10.1155/1998/760324

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  2 in total

1.  Modified method of AgNOR staining for tissue and interpretation in histopathology.

Authors:  Mulazim Hussain Bukhari; Shahida Niazi; Saeed Akhter Khan; Ihsanulla Hashmi; Shahida Perveen; Shahzad Shafqat Qureshi; Naseer Ahmed Chaudhry; G R Qureshi; Mumtaz Hasan
Journal:  Int J Exp Pathol       Date:  2007-02       Impact factor: 1.925

Review 2.  Measuring proliferation in breast cancer: practicalities and applications.

Authors:  Mark J Beresford; George D Wilson; Andreas Makris
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.